Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Anchorage

Phoenix

Tempe

Tucson

Orange

San Francisco

Aurora

Denver

New Haven

Newark

Washington D.C.

Gainesville

Miami Beach

Chicago

Evanston

Fort Wayne

Sioux City

Westwood

Louisville

Baltimore

Ann Arbor

Detroit

Rochester

Woodbury

St Louis

Billings

Omaha

Morristown

New York

Rochester

Charlotte

Goldsboro

Cincinnati

Cleveland

Portland

Philadelphia

Pittsburgh

Sioux Falls

Arlington

Dallas

Grapevine

San Antonio

The Woodlands

Tyler

Waco

Salt Lake City

Fairfax

Seattle

Madison

Brussels

Ghent

Kortrijk

Leuven

Montpellier

Villejuif

Avignon

Clichy

Paris

Toulouse

Berlin

Bonn

Dresden

Hanover

Homburg

Leipzig

Mainz

Tübingen

Jerusalem

Petah Tikva

Ramat Gan

Tel Aviv

Bari

San Giovanni Rotondo

Bergamo

Bologna

Candiolo

Catania

Faenza

Lecce

Meldola

Milan

Napoli

Rimini

Siena

Verona

Nagoya

Chiba

Fukuoka

Yokohama

Kyoto

Osaka

Osakasayama-shi

Kitaadachi

Sunto

Kōtoku

Shinjuku-ku

Goyang-si

Seongnam-si

Seoul

Pamplona

Barcelona

Girona

Madrid

Taichung

Tainan City

Taipei

Chiang Mai

Khon Kaen

Udon Thani

Bangkok

Bangkoknoi

Cambridge

Bournemouth

Aberdeen

London

Cardiff

Glasgow

Manchester

Metropolitan Borough of Wirral

Sheffield